Seeing Is Believing

Currently out of the existing stock ratings of Greg Harrison, 85 are a BUY (71.43%), 29 are a HOLD (24.37%), 5 are a SELL (4.2%).
Analyst Greg Harrison, currently employed at BAML, carries an average stock price target met ratio of 58% that have a potential upside of 37.1% achieved within 159 days.
Greg Harrison’s has documented 231 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 01-Sep-2025.
Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for OMER (OMEROS) at 11/8/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.2 (6.25%) receiving and performance score of 62.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6.25
$6.24 (62400.00%)
$25
3 years 5 months ago
(23-May-2022)
1/3 (33.33%)
$0.9 (16.82%)
14
Buy
$11
4 years 8 months 6 days ago
(17-Feb-2021)
1/1 (100%)
$-23.25 (-67.88%)
998
Buy
$125
$124.57 (28969.77%)
5 years 5 months 15 days ago
(08-May-2020)
0/1 (0%)
$54 (76.06%)
Which stock is Greg Harrison is most bullish on?
Which stock is Greg Harrison is most reserved on?
What Year was the first public recommendation made by Greg Harrison?